BIOTECH Logo

BIOTECH

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Biat Group is a biotechnology corporate group that operates through its holding company, Bionatur, and a global commercial network. The group is composed of several subsidiaries with distinct specializations. Biobide is a leading provider of preclinical research, offering toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions leverages a proprietary set of inteins for high-value applications in gene therapy, immunotherapy, in-vitro diagnostics (IVD), smart vaccines, and protein purification. The Bionatur division holds unique biotech assets for human and animal health. The group seeks collaborations in licensing, preclinical research, and vaccine improvement.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for BIOTECH. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-19 14:18
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-18 10:30
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-17 14:38
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-14 10:53
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-13 15:33
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-12 14:50
Net Asset Value
Net Asset Value(s)
English 4.1 KB
2025-03-11 15:54
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-10 14:35
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-07 14:28
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-07 09:08
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-06 15:30
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-06 08:00
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-05 14:34
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-04 14:40
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-03 15:43
Net Asset Value
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Enlivex Therapeutics Ltd. Logo
Developing a cell therapy platform to treat inflammatory diseases by reprogramming macrophages.
Israel ENLV
E-Novia Logo
A deep-tech factory building Physical AI ventures for mobility, logistics, and automation.
Italy E9IA
ERYTECH Pharma S.A. Logo
Biopharma firm developing phage therapies to fight antimicrobial resistance (AMR).
France ERYP
EUROESPES Logo
Research & patient care for CNS diseases via personalized genomic medicine.
Spain EEP
Eurofins-Cerep Logo
CRO offering preclinical drug profiling, screening & pharmacology testing for pharma/biotech.
France ALECR
Evogene Ltd. Logo
An AI-powered computational biology platform for life-science products in health and agriculture.
Israel EVGN
Evotec SE Logo
A drug discovery and development partner for pharma, biotech, and academia.
Germany EVT
EXACT Therapeutics AS Logo
Biopharma developing ultrasound technology for targeted drug delivery in oncology.
Norway EXTX
ExpreS2ion Biotech Holding AB Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using a protein platform.
Sweden EXPRS2
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN